Cantor Fitzgerald Maintains Neutral on Trupanion, Lowers Price Target to $30
Cantor Fitzgerald analyst Ryan Tunis maintains Trupanion (NASDAQ:TRUP) with a Neutral and lowers the price target from $34 to $30.
Stocks · News reference
Trupanion Announces $100M Buyback Plan
Trupanion, Inc. (NASDAQ:TRUP), a leading provider of medical insurance for cats and dogs, today announced its Board has authorized a share repurchase program, pursuant to which the Company may repurchase up to an
Reference Details
Connected Markets
Poisar stores the source's headline, summary and market tags for reference. Reporting and full article text remain with the original publisher.
- Source
- benzinga
- Observed
- Checked
- Cadence
- Captured once, then retained as an archive reference
- Status
- fresh
Keep reading
Related Headlines
Piper Sandler Downgrades Trupanion to Neutral, Lowers Price Target to $32
Piper Sandler analyst David Westenberg downgrades Trupanion (NASDAQ:TRUP) from Overweight to Neutral and lowers the price target from $45 to $32.
Stifel Maintains Hold on Trupanion, Raises Price Target to $29
Stifel analyst Jonathan Block maintains Trupanion (NASDAQ:TRUP) with a Hold and raises the price target from $28 to $29.
Trupanion Sees Q3 Sales $399.000M-$405.000M vs $398.218M Est
Trupanion (NASDAQ:TRUP) sees Q3 sales of $399.000 million-$405.000 million vs $398.218 million analyst estimate.